Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 276

1.

Diabetic kidney disease: Its current trends and future therapeutic perspectives.

Koya D.

J Diabetes Investig. 2019 Sep;10(5):1174-1176. doi: 10.1111/jdi.13121. Epub 2019 Aug 22. No abstract available.

2.

Prevalence of albuminuria and renal dysfunction, and related clinical factors in Japanese patients with diabetes: The Japan Diabetes Complication and its Prevention prospective study 5.

Shikata K, Kodera R, Utsunomiya K, Koya D, Nishimura R, Miyamoto S, Tajima N; JDCP study group.

J Diabetes Investig. 2019 Jul 18. doi: 10.1111/jdi.13116. [Epub ahead of print]

3.

Proposal of classification of "chronic kidney disease (CKD) with diabetes" in clinical setting.

Kitada M, Koya D.

Diabetol Int. 2019 Apr 29;10(3):180-182. doi: 10.1007/s13340-019-00396-8. eCollection 2019 Jul.

PMID:
31275783
4.

Relevance of Autophagy Induction by Gastrointestinal Hormones: Focus on the Incretin-Based Drug Target and Glucagon.

Kanasaki K, Kawakita E, Koya D.

Front Pharmacol. 2019 May 16;10:476. doi: 10.3389/fphar.2019.00476. eCollection 2019. Review.

5.

Dipeptidyl peptidase-4 plays a pathogenic role in BSA-induced kidney injury in diabetic mice.

Takagaki Y, Shi S, Katoh M, Kitada M, Kanasaki K, Koya D.

Sci Rep. 2019 May 17;9(1):7519. doi: 10.1038/s41598-019-43730-5.

7.

The impact of dietary protein intake on longevity and metabolic health.

Kitada M, Ogura Y, Monno I, Koya D.

EBioMedicine. 2019 May;43:632-640. doi: 10.1016/j.ebiom.2019.04.005. Epub 2019 Apr 8. Review.

8.

βklotho is essential for the anti-endothelial mesenchymal transition effects of N-acetyl-seryl-aspartyl-lysyl-proline.

Gao R, Kanasaki K, Li J, Kitada M, Okazaki T, Koya D.

FEBS Open Bio. 2019 May;9(5):1029-1038. doi: 10.1002/2211-5463.12638. Epub 2019 Apr 22.

9.

Sirtuins and Type 2 Diabetes: Role in Inflammation, Oxidative Stress, and Mitochondrial Function.

Kitada M, Ogura Y, Monno I, Koya D.

Front Endocrinol (Lausanne). 2019 Mar 27;10:187. doi: 10.3389/fendo.2019.00187. eCollection 2019. Review.

10.

N-Acetyl-seryl-aspartyl-lysyl-proline is a potential biomarker of renal function in normoalbuminuric diabetic patients with eGFR ≥ 30 ml/min/1.73 m2.

Nitta K, Nagai T, Mizunuma Y, Kitada M, Nakagawa A, Sakurai M, Toyoda M, Haneda M, Kanasaki K, Koya D.

Clin Exp Nephrol. 2019 Aug;23(8):1004-1012. doi: 10.1007/s10157-019-01733-6. Epub 2019 Apr 4.

PMID:
30949886
11.

Inhibition of Dipeptidyl Peptidase-4 Accelerates Epithelial-Mesenchymal Transition and Breast Cancer Metastasis via the CXCL12/CXCR4/mTOR Axis.

Yang F, Takagaki Y, Yoshitomi Y, Ikeda T, Li J, Kitada M, Kumagai A, Kawakita E, Shi S, Kanasaki K, Koya D.

Cancer Res. 2019 Feb 15;79(4):735-746. doi: 10.1158/0008-5472.CAN-18-0620. Epub 2018 Dec 24.

PMID:
30584072
12.

Secular changes in clinical manifestations of kidney disease among Japanese adults with type 2 diabetes from 1996 to 2014.

Kume S, Araki SI, Ugi S, Morino K, Koya D, Nishio Y, Haneda M, Kashiwagi A, Maegawa H.

J Diabetes Investig. 2019 Jul;10(4):1032-1040. doi: 10.1111/jdi.12977. Epub 2019 Jan 1.

13.

AMP-Activated Protein (AMPK) in Pathophysiology of Pregnancy Complications.

Kumagai A, Itakura A, Koya D, Kanasaki K.

Int J Mol Sci. 2018 Oct 9;19(10). pii: E3076. doi: 10.3390/ijms19103076. Review.

14.

SIRT3 deficiency leads to induction of abnormal glycolysis in diabetic kidney with fibrosis.

Srivastava SP, Li J, Kitada M, Fujita H, Yamada Y, Goodwin JE, Kanasaki K, Koya D.

Cell Death Dis. 2018 Sep 24;9(10):997. doi: 10.1038/s41419-018-1057-0.

15.

Effect of switching to teneligliptin from other dipeptidyl peptidase-4 inhibitors on glucose control and renoprotection in type 2 diabetes patients with diabetic kidney disease.

Kitada M, Ogura Y, Nitta K, Fujii M, Kanasaki K, Konishi K, Iida Y, Nakagawa A, Koya D.

J Diabetes Investig. 2019 May;10(3):706-713. doi: 10.1111/jdi.12917. Epub 2018 Oct 1.

16.

The Japanese Clinical Practice Guideline for acute kidney injury 2016.

Doi K, Nishida O, Shigematsu T, Sadahiro T, Itami N, Iseki K, Yuzawa Y, Okada H, Koya D, Kiyomoto H, Shibagaki Y, Matsuda K, Kato A, Hayashi T, Ogawa T, Tsukamoto T, Noiri E, Negi S, Kamei K, Kitayama H, Kashihara N, Moriyama T, Terada Y; Japanese Clinical Practice Guideline for Acute Kidney Injury 2016 Committee.

J Intensive Care. 2018 Aug 13;6:48. doi: 10.1186/s40560-018-0308-6. eCollection 2018.

17.

The Japanese clinical practice guideline for acute kidney injury 2016.

Doi K, Nishida O, Shigematsu T, Sadahiro T, Itami N, Iseki K, Yuzawa Y, Okada H, Koya D, Kiyomoto H, Shibagaki Y, Matsuda K, Kato A, Hayashi T, Ogawa T, Tsukamoto T, Noiri E, Negi S, Kamei K, Kitayama H, Kashihara N, Moriyama T, Terada Y; Japanese Clinical Practice Guideline for Acute Kidney Injury 2016 Committee.

Clin Exp Nephrol. 2018 Oct;22(5):985-1045. doi: 10.1007/s10157-018-1600-4. Review.

18.

Role of dietary amino acid balance in diet restriction-mediated lifespan extension, renoprotection, and muscle weakness in aged mice.

Yoshida S, Yamahara K, Kume S, Koya D, Yasuda-Yamahara M, Takeda N, Osawa N, Chin-Kanasaki M, Adachi Y, Nagao K, Maegawa H, Araki SI.

Aging Cell. 2018 Aug;17(4):e12796. doi: 10.1111/acel.12796. Epub 2018 Jun 25.

19.

Renal mitochondrial oxidative stress is enhanced by the reduction of Sirt3 activity, in Zucker diabetic fatty rats.

Ogura Y, Kitada M, Monno I, Kanasaki K, Watanabe A, Koya D.

Redox Rep. 2018 Dec;23(1):153-159. doi: 10.1080/13510002.2018.1487174.

PMID:
29897845
20.

Severe electrolytes disorders with the interstitial kidney alterations in the patient with the history of total thyroidectomy and parathyroidectomy: possible role of vitamin D deficiency.

Kawakita E, Kanasaki K, Hirai T, Tsuda SI, Watanabe A, Nitta K, Kitada M, Ogura Y, Takagaki Y, Fujii M, Nagai T, Shimada K, Takagi S, Mizunuma Y, Monno I, Shino F, Minato H, Miyatake N, Nakagawa A, Koya D.

Clin Case Rep. 2018 Apr 6;6(6):983-989. doi: 10.1002/ccr3.1500. eCollection 2018 Jun.

21.

A Low-Protein Diet for Diabetic Kidney Disease: Its Effect and Molecular Mechanism, an Approach from Animal Studies.

Kitada M, Ogura Y, Monno I, Koya D.

Nutrients. 2018 Apr 27;10(5). pii: E544. doi: 10.3390/nu10050544. Review.

22.

A ketogenic amino acid rich diet benefits mitochondrial homeostasis by altering the AKT/4EBP1 and autophagy signaling pathways in the gastrocnemius and soleus.

Li J, Kanasaki M, Xu L, Kitada M, Nagao K, Adachi Y, Jinzu H, Noguchi Y, Kohno M, Kanasaki K, Koya D.

Biochim Biophys Acta Gen Subj. 2018 Jul;1862(7):1547-1555. doi: 10.1016/j.bbagen.2018.03.013. Epub 2018 Mar 15.

PMID:
29550428
23.

A low-protein diet exerts a beneficial effect on diabetic status and prevents diabetic nephropathy in Wistar fatty rats, an animal model of type 2 diabetes and obesity.

Kitada M, Ogura Y, Suzuki T, Monno I, Kanasaki K, Watanabe A, Koya D.

Nutr Metab (Lond). 2018 Mar 2;15:20. doi: 10.1186/s12986-018-0255-1. eCollection 2018.

24.

Ipragliflozin improves mitochondrial abnormalities in renal tubules induced by a high-fat diet.

Takagi S, Li J, Takagaki Y, Kitada M, Nitta K, Takasu T, Kanasaki K, Koya D.

J Diabetes Investig. 2018 Sep;9(5):1025-1032. doi: 10.1111/jdi.12802. Epub 2018 Mar 12.

25.

FGFR1 is essential for N-acetyl-seryl-aspartyl-lysyl-proline regulation of mitochondrial dynamics by upregulating microRNA let-7b-5p.

Hu Q, Li J, Nitta K, Kitada M, Nagai T, Kanasaki K, Koya D.

Biochem Biophys Res Commun. 2018 Jan 15;495(3):2214-2220. doi: 10.1016/j.bbrc.2017.12.089. Epub 2017 Dec 18.

PMID:
29269295
26.

The Effect of Piceatannol from Passion Fruit (Passiflora edulis) Seeds on Metabolic Health in Humans.

Kitada M, Ogura Y, Maruki-Uchida H, Sai M, Suzuki T, Kanasaki K, Hara Y, Seto H, Kuroshima Y, Monno I, Koya D.

Nutrients. 2017 Oct 18;9(10). pii: E1142. doi: 10.3390/nu9101142.

27.

Decline in estimated glomerular filtration rate is associated with risk of end-stage renal disease in type 2 diabetes with macroalbuminuria: an observational study from JDNCS.

Shimizu M, Furuichi K, Toyama T, Funamoto T, Kitajima S, Hara A, Ogawa D, Koya D, Ikeda K, Koshino Y, Kurokawa Y, Abe H, Mori K, Nakayama M, Konishi Y, Samejima KI, Matsui M, Yamauchi H, Gohda T, Fukami K, Nagata D, Yamazaki H, Yuzawa Y, Suzuki Y, Fujimoto S, Maruyama S, Kato S, Naito T, Yoshimura K, Yokoyama H, Wada T; Research Group of Diabetic Nephropathy, the Ministry of Health, Labour, and Welfare of Japan and Japan Agency for Medical Research and Development.

Clin Exp Nephrol. 2018 Apr;22(2):377-387. doi: 10.1007/s10157-017-1467-9. Epub 2017 Sep 9.

PMID:
28889347
28.

Eplerenone prevented obesity-induced inflammasome activation and glucose intolerance.

Wada T, Ishikawa A, Watanabe E, Nakamura Y, Aruga Y, Hasegawa H, Onogi Y, Honda H, Nagai Y, Takatsu K, Ishii Y, Sasahara M, Koya D, Tsuneki H, Sasaoka T.

J Endocrinol. 2017 Dec;235(3):179-191. doi: 10.1530/JOE-17-0351. Epub 2017 Aug 30.

PMID:
28855315
29.

Cyclic and intermittent very low-protein diet can have beneficial effects against advanced diabetic nephropathy in Wistar fatty (fa/fa) rats, an animal model of type 2 diabetes and obesity.

Kitada M, Ogura Y, Suzuki T, Monnno I, Kanasaki K, Watanabe A, Koya D.

Nephrology (Carlton). 2017 Dec;22(12):1030-1034. doi: 10.1111/nep.13152.

PMID:
28802091
30.

Deficiency in catechol-o-methyltransferase is linked to a disruption of glucose homeostasis in mice.

Kanasaki M, Srivastava SP, Yang F, Xu L, Kudoh S, Kitada M, Ueki N, Kim H, Li J, Takeda S, Kanasaki K, Koya D.

Sci Rep. 2017 Aug 11;7(1):7927. doi: 10.1038/s41598-017-08513-w.

31.

FGFR1 is critical for the anti-endothelial mesenchymal transition effect of N-acetyl-seryl-aspartyl-lysyl-proline via induction of the MAP4K4 pathway.

Li J, Shi S, Srivastava SP, Kitada M, Nagai T, Nitta K, Kohno M, Kanasaki K, Koya D.

Cell Death Dis. 2017 Aug 3;8(8):e2965. doi: 10.1038/cddis.2017.353.

32.

Anagliptin ameliorates albuminuria and urinary liver-type fatty acid-binding protein excretion in patients with type 2 diabetes with nephropathy in a glucose-lowering-independent manner.

Kitada M, Tsuda SI, Konishi K, Takeda-Watanabe A, Fujii M, Kanasaki K, Nishizawa M, Nakagawa A, Koya D.

BMJ Open Diabetes Res Care. 2017 Jul 7;5(1):e000391. doi: 10.1136/bmjdrc-2017-000391. eCollection 2017. Erratum in: BMJ Open Diabetes Res Care. 2017 Sep 7;5(1):e000391corr1.

33.

Regulating Autophagy as a Therapeutic Target for Diabetic Nephropathy.

Kitada M, Ogura Y, Monno I, Koya D.

Curr Diab Rep. 2017 Jul;17(7):53. doi: 10.1007/s11892-017-0879-y. Review.

PMID:
28593583
34.

Catechol-O-Methyltransferase Deficiency Leads to Hypersensitivity of the Pressor Response Against Angiotensin II.

Ueki N, Kanasaki K, Kanasaki M, Takeda S, Koya D.

Hypertension. 2017 Jun;69(6):1156-1164. doi: 10.1161/HYPERTENSIONAHA.117.09247. Epub 2017 May 1.

PMID:
28461606
35.

PDGFRβ Regulates Adipose Tissue Expansion and Glucose Metabolism via Vascular Remodeling in Diet-Induced Obesity.

Onogi Y, Wada T, Kamiya C, Inata K, Matsuzawa T, Inaba Y, Kimura K, Inoue H, Yamamoto S, Ishii Y, Koya D, Tsuneki H, Sasahara M, Sasaoka T.

Diabetes. 2017 Apr;66(4):1008-1021. doi: 10.2337/db16-0881. Epub 2017 Jan 25.

36.

Diabetic nephropathy: advances in treatment.

Kitada M, Koya D.

Nihon Jinzo Gakkai Shi. 2017;59(2):74-78. English, Japanese. No abstract available.

PMID:
30549916
37.

Diabetic nephropathy

Kitada M, Koya D.

Nihon Jinzo Gakkai Shi. 2017;59(2):38-42. Japanese. No abstract available.

PMID:
30549911
38.

Impact of empagliflozin on diabetic kidney disease.

Koya D.

J Diabetes Investig. 2017 Sep;8(5):658-660. doi: 10.1111/jdi.12615. Epub 2017 Feb 22.

39.

Comparative Effects of Direct Renin Inhibitor and Angiotensin Receptor Blocker on Albuminuria in Hypertensive Patients with Type 2 Diabetes. A Randomized Controlled Trial.

Uzu T, Araki SI, Kashiwagi A, Haneda M, Koya D, Yokoyama H, Kida Y, Ikebuchi M, Nakamura T, Nishimura M, Takahara N, Obata T, Omichi N, Sakamoto K, Shingu R, Taki H, Nagai Y, Tokuda H, Kitada M, Misawa M, Nishiyama A, Kobori H, Maegawa H; Shiga Committee for Preventing Diabetic Nephropathy.

PLoS One. 2016 Dec 29;11(12):e0164936. doi: 10.1371/journal.pone.0164936. eCollection 2016.

40.

Hypothalamic AMP-Activated Protein Kinase Regulates Biphasic Insulin Secretion from Pancreatic β Cells during Fasting and in Type 2 Diabetes.

Kume S, Kondo M, Maeda S, Nishio Y, Yanagimachi T, Fujita Y, Haneda M, Kondo K, Sekine A, Araki SI, Araki H, Chin-Kanasaki M, Ugi S, Koya D, Kitahara S, Maeda K, Kashiwagi A, Uzu T, Maegawa H.

EBioMedicine. 2016 Nov;13:168-180. doi: 10.1016/j.ebiom.2016.10.038. Epub 2016 Oct 28.

41.

Restoration of the Hypothalamic-pituitary-adrenal Response to Hypoglycemia in Type 2 Diabetes by Avoiding Chronic Hypoglycemia.

Tsuda SI, Konishi K, Otoda T, Nagai T, Takeda-Watanabe A, Kanasaki M, Kitada M, Nakagawa A, Nishizawa M, Kanasaki K, Koya D.

Intern Med. 2016;55(23):3471-3473. Epub 2016 Dec 1.

42.

Rodent models of diabetic nephropathy: their utility and limitations.

Kitada M, Ogura Y, Koya D.

Int J Nephrol Renovasc Dis. 2016 Nov 14;9:279-290. eCollection 2016. Review.

43.

Dipeptidyl peptidase-4 inhibition and renoprotection: the role of antifibrotic effects.

Takagaki Y, Koya D, Kanasaki K.

Curr Opin Nephrol Hypertens. 2017 Jan;26(1):56-66. Review.

PMID:
27820706
44.

The protective role of Sirt1 in vascular tissue: its relationship to vascular aging and atherosclerosis.

Kitada M, Ogura Y, Koya D.

Aging (Albany NY). 2016 Oct 15;8(10):2290-2307. doi: 10.18632/aging.101068. Review.

45.

MicroRNA148b-3p inhibits mTORC1-dependent apoptosis in diabetes by repressing TNFR2 in proximal tubular cells.

Kuwagata S, Kume S, Chin-Kanasaki M, Araki H, Araki S, Nakazawa J, Sugaya T, Koya D, Haneda M, Maegawa H, Uzu T.

Kidney Int. 2016 Dec;90(6):1211-1225. doi: 10.1016/j.kint.2016.06.036. Epub 2016 Aug 31.

PMID:
27591086
46.

Effect of Antifibrotic MicroRNAs Crosstalk on the Action of N-acetyl-seryl-aspartyl-lysyl-proline in Diabetes-related Kidney Fibrosis.

Srivastava SP, Shi S, Kanasaki M, Nagai T, Kitada M, He J, Nakamura Y, Ishigaki Y, Kanasaki K, Koya D.

Sci Rep. 2016 Jul 18;6:29884. doi: 10.1038/srep29884.

47.

[Protein kinase C pathway].

Kitada M, Koya D.

Nihon Rinsho. 2016 Apr;74 Suppl 2:61-6. Japanese. No abstract available.

PMID:
27266063
48.

Oral Administration of N-Acetyl-seryl-aspartyl-lysyl-proline Ameliorates Kidney Disease in Both Type 1 and Type 2 Diabetic Mice via a Therapeutic Regimen.

Nitta K, Shi S, Nagai T, Kanasaki M, Kitada M, Srivastava SP, Haneda M, Kanasaki K, Koya D.

Biomed Res Int. 2016;2016:9172157. doi: 10.1155/2016/9172157. Epub 2016 Mar 20.

49.

Rapid enlargement of an intracranial germ cell tumor after gonadotropin hormone therapy.

Sasagawa Y, Tachibana O, Nakagawa A, Nakada S, Nojima T, Koya D, Iizuka H.

J Clin Neurosci. 2016 Sep;31:185-8. doi: 10.1016/j.jocn.2016.01.033. Epub 2016 Apr 2.

PMID:
27050912
50.

A very-low-protein diet ameliorates advanced diabetic nephropathy through autophagy induction by suppression of the mTORC1 pathway in Wistar fatty rats, an animal model of type 2 diabetes and obesity.

Kitada M, Ogura Y, Suzuki T, Sen S, Lee SM, Kanasaki K, Kume S, Koya D.

Diabetologia. 2016 Jun;59(6):1307-17. doi: 10.1007/s00125-016-3925-4. Epub 2016 Mar 28.

PMID:
27020449

Supplemental Content

Support Center